Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis

J. Lee (Aurora, United States of America), J. La (San Francisco, United States of America), S. Aziz (San Francisco, United States of America), R. Brownell (San Francisco, United States of America), K. Jones (San Francisco, United States of America), G. Green (San Francisco, United States of America), B. Elicker (San Francisco, United States of America), J. Golden (San Francisco, United States of America), M. Matthay (San Francisco, United States of America), J. Kukreja (San Francisco, United States of America), H. Collard (San Francisco, United States of America), P. Wolters (San Francisco, United States of America)

Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Session: Progress in basic and translational research on idiopathic interstitial pneumonias
Session type: Oral Presentation
Number: 5362
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Lee (Aurora, United States of America), J. La (San Francisco, United States of America), S. Aziz (San Francisco, United States of America), R. Brownell (San Francisco, United States of America), K. Jones (San Francisco, United States of America), G. Green (San Francisco, United States of America), B. Elicker (San Francisco, United States of America), J. Golden (San Francisco, United States of America), M. Matthay (San Francisco, United States of America), J. Kukreja (San Francisco, United States of America), H. Collard (San Francisco, United States of America), P. Wolters (San Francisco, United States of America). Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis. 5362

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Resistance Training Alone Improves Lung Inflammation and Respiratory Muscle Strenght but not Lung Function and Mechanics in Mid-Age Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Severity of Bronchiectasis and Lung Functions Related with the Genotype of Primary Ciliary Dyskinesia Patients
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020


Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Respiratory Symptoms and Lung Function Depend on Smoking Status and Enviromental Conditions
Source: International Congress 2017 – Smoking, apnoea, infection, allergens and other factors
Year: 2017

Use of Telemetry and Plethysmography to Assess Respiratory Function in Conscious Rats with Bleomycin-Induced Lung Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Aerobic and Weightlifting Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Overweight Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Dynamic Balance, Exercise Capacity and Muscle Oxygenation in Children with Non Cystic Fibrosis Bronchiectasis
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Computed Tomography Findings as Determinants of Pulmonary Function Tests in Fibrotic Interstitial Lung Diseases
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020

Visceral Fat is More Related to Impairment of Lung Function and Mechanics and Pulmonary Immune Response in Overweight and Grade I Obese Women
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021

Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019